Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Doxacurium chloride
Drug ID BADD_D00715
Description Doxacurium chloride is a long-acting, nondepolarizing skeletal muscle relaxant for intravenous administration.
Indications and Usage Used to provide skeletal muscle relaxation as an adjunct to general anesthesia, for endotracheal intubation or to facilitate mechanical ventilation.
Marketing Status Discontinued
ATC Code M03AC07
DrugBank ID DB01135
KEGG ID D00760
MeSH ID C049429
PubChem ID 60168
TTD Drug ID D0Y7TO
NDC Product Code Not Available
Synonyms doxacurium | doxacurium chloride | 2,2'-((1,4-dioxobutane-1,4-diyl)bis(oxypropane-3,1-diyl))bis(6,7,8-trimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolinium) dichloride | BW A938U | BW-A-938U | BW-A938U | BW-A 938U | Nuromax
Chemical Information
Molecular Formula C56H78Cl2N2O16
CAS Registry Number 83348-52-1
SMILES C[N+]1(CCC2=CC(=C(C(=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)OC)CCCOC(=O)CCC(=O)OCCC[ N+]4(CCC5=CC(=C(C(=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)OC)C.[Cl-].[Cl-]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Bronchospasm22.03.01.004; 10.01.03.012--
Diplopia17.17.01.005; 06.02.06.002--Not Available
Drug effect prolonged08.06.01.012--Not Available
Flushing23.06.05.003; 08.01.03.025; 24.03.01.002--
Hypotension24.06.03.002--
Injection site reaction12.07.03.015; 08.02.03.014--
Myocardial infarction24.04.04.009; 02.02.02.007--
Pyrexia08.05.02.003--
Urticaria10.01.06.001; 23.04.02.001--
Ventricular fibrillation02.03.04.008--
Wheezing22.03.01.009--
Neuromuscular blockade reversal25.01.03.002--Not Available
The 1th Page    1    Total 1 Pages